Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $4.92 +0.12 (+2.50%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends HSAQ vs. CATX, PROF, DRTS, UTMD, KRMD, ARAY, OBIO, SKIN, INFU, and SGHTShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include Perspective Therapeutics (CATX), Profound Medical (PROF), Alpha Tau Medical (DRTS), Utah Medical Products (UTMD), KORU Medical Systems (KRMD), Accuray (ARAY), Orchestra BioMed (OBIO), Beauty Health (SKIN), InfuSystem (INFU), and Sight Sciences (SGHT). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Perspective Therapeutics Profound Medical Alpha Tau Medical Utah Medical Products KORU Medical Systems Accuray Orchestra BioMed Beauty Health InfuSystem Sight Sciences Perspective Therapeutics (NYSE:CATX) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership. Which has more risk and volatility, CATX or HSAQ? Perspective Therapeutics has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Does the media prefer CATX or HSAQ? In the previous week, Perspective Therapeutics had 1 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 1 mentions for Perspective Therapeutics and 0 mentions for Health Sciences Acquisitions Co. 2. Perspective Therapeutics' average media sentiment score of 1.24 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Perspective Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Perspective Therapeutics Positive Health Sciences Acquisitions Co. 2 Neutral Is CATX or HSAQ more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Perspective Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Perspective Therapeutics-4,096.66% -27.40% -23.16% Health Sciences Acquisitions Co. 2 N/A N/A -2.38% Which has preferable earnings and valuation, CATX or HSAQ? Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than Perspective Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerspective Therapeutics$1.43M134.70-$46.51MN/AN/AHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A Do analysts recommend CATX or HSAQ? Perspective Therapeutics presently has a consensus price target of $15.14, suggesting a potential upside of 431.33%. Given Perspective Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Perspective Therapeutics is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perspective Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in CATX or HSAQ? 54.7% of Perspective Therapeutics shares are held by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. 3.5% of Perspective Therapeutics shares are held by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor CATX or HSAQ? Perspective Therapeutics received 18 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformPerspective TherapeuticsOutperform Votes1894.74% Underperform Votes15.26%Health Sciences Acquisitions Co. 2N/AN/A SummaryPerspective Therapeutics beats Health Sciences Acquisitions Co. 2 on 8 of the 14 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.16M$4.33B$5.10B$9.07BDividend YieldN/A41.46%4.90%4.21%P/E RatioN/A25.3791.0817.15Price / SalesN/A45.671,113.51116.81Price / CashN/A43.4642.2637.86Price / Book-7.947.364.784.78Net Income-$380,000.00$13.64M$119.77M$225.60M7 Day Performance-6.46%-2.82%-1.87%-1.23%1 Month Performance-6.82%0.54%11.46%3.07%1 Year Performance-47.99%41.80%30.53%16.48% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$4.92+2.5%N/A-51.8%$55.16MN/A0.004Gap UpCATXPerspective Therapeutics3.3613 of 5 stars$3.49+0.3%$15.14+333.9%N/A$235.88M$1.43M0.00116Positive NewsPROFProfound Medical2.5416 of 5 stars$7.27-1.8%$13.75+89.1%-12.8%$218.32M$7.20M-5.52150High Trading VolumeDRTSAlpha Tau Medical1.9691 of 5 stars$3.09+0.7%$8.00+158.9%+10.3%$216.07MN/A-7.1480UTMDUtah Medical Products3.1165 of 5 stars$62.95+0.5%N/A-27.9%$213.40M$50.22M14.73180Positive NewsKRMDKORU Medical Systems1.328 of 5 stars$4.29-0.2%$4.13-3.8%+74.0%$196.65M$28.52M-17.2080ARAYAccuray4.5709 of 5 stars$1.95+1.3%$9.00+362.7%-33.5%$195.60M$444.20M-11.29987News CoveragePositive NewsOBIOOrchestra BioMed2.0616 of 5 stars$5.12-2.7%$15.75+207.6%-49.8%$194.63M$2.65M-3.2756News CoveragePositive NewsGap DownSKINBeauty Health1.8107 of 5 stars$1.56-1.6%$2.55+64.0%-54.1%$193.01M$398M-3.761,030INFUInfuSystem1.5787 of 5 stars$8.84-0.8%$13.00+47.1%N/A$187.97M$132.78M148.50499SGHTSight Sciences3.0352 of 5 stars$3.66+2.2%$5.12+39.9%+7.2%$185.78M$81.06M-3.51210News CoverageGap Up Related Companies and Tools Related Companies Perspective Therapeutics Competitors Profound Medical Competitors Alpha Tau Medical Competitors Utah Medical Products Competitors KORU Medical Systems Competitors Accuray Competitors Orchestra BioMed Competitors Beauty Health Competitors InfuSystem Competitors Sight Sciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSAQ) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSAQ Stock Alerts